CHA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CHA is not a clear buy right now for a beginner long-term investor with $50,000-$100,000. The stock shows short-term technical improvement and a positive analyst shift, but the latest quarter still shows weak revenue and sharply lower earnings. With no strong proprietary buy signal and no recent news catalyst, the better call is to hold and wait for more proof of a sustained turnaround before committing large long-term capital.
CHA is trying to stabilize. The MACD histogram is positive and expanding, which supports near-term upside momentum. RSI_6 at 66.5 is elevated but not overbought enough to confirm a strong breakout. Moving averages are converging, suggesting a transition phase rather than a confirmed trend. Price closed at 11.02, just below R1 at 11.117 and above pivot at 10.758, so the stock is sitting near a key decision area. The short-term pattern data also points to modest upside probability over the next day, week, and month, but this is not yet a strong long-term technical buy setup.
JPMorgan upgraded CHA to Overweight with a higher price target of $16, citing a clearer path to stabilization and recovery. The analyst noted that same-store-sales declines are narrowing, which suggests operational improvement may be starting. Gross margin improved to 53.18% in the latest quarter, showing better product economics. The stock also has a positive short-term momentum profile and closed above its pivot level.
No news was reported in the past week, so there is no fresh event-driven catalyst. The latest quarter showed revenue down 10.79% YoY, net income down 95.33% YoY, and EPS down 95.50% YoY, which is a major earnings deterioration. Hedge funds and insiders are both neutral, and there is no recent congress trading data or influential figure buying signal to support the thesis. AI Stock Picker and SwingMax both show no signal today, so there is no proprietary trigger for an aggressive entry.
In 2025/Q4, Chagee reported weaker operating results overall. Revenue fell 10.79% YoY to 2,974,485,000, while net income dropped 95.33% YoY to 28,538,000 and EPS declined 95.50% YoY to 0.15. The main positive was gross margin expansion to 53.18%, up 3.08% YoY, which suggests some cost or pricing improvement. However, the sharp profit decline outweighs the margin strength for a long-term beginner investor.
Analyst sentiment has improved. On 2026-04-02, JPMorgan upgraded Chagee to Overweight from Neutral and raised its price target to $16 from $11.50, saying the worst of same-store-sales declines may be behind the company and that recovery looks more visible. Earlier, on 2026-02-13, JPMorgan had upgraded it to Neutral from Underweight with a $11.50 target, describing the shares as heavily de-rated and nearing a pivot point. The Wall Street view is now more constructive, but the fundamental recovery still needs confirmation.
